HAVCR2 and idiopathic pulmonary fibrosis: Although we do not have a conclusive explanation for the apparent contradictory results, it suggests that high TIM-3 levels obtained by transgenic overexpression differentially affect pulmonary fibrosis as compared to endogenous levels in IPF patients.